Articles by admin

Callaway Golf Company (NYSE:ELY), which is in the leisure business, and is based in United States, saw a decent share… …read more […]

For more risk-tolerant investors, biotechs are screaming buys. This space is consistently on the Street’s radar as a single catalyst such as a positive FDA advisory committee (AdCom) outcome or promising trial results can send shares through the roof. For example, Agile Therapeutics (AGRX) saw share prices skyrocket 223% in just one day after an FDA AdCom vote resulted in an approval recommendation for its Twirla contraceptive patch. However, the reverse also holds true meaning that biotech stocks carry their fair share of risk. So how are investors supposed to pick the biotech names most poised to outperform …read more […]

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously… …read more […]

Legendary fund manager Li Lu (who Charlie Munger backed) once said, ‘The biggest investment risk is not the volatility… …read more […]

Half Year 2020 Ryanair Holdings PLC Earnings Pre-Recorded Presentation …read more […]

Warren Buffett famously said, ‘Volatility is far from synonymous with risk.’ When we think about how risky a company… …read more […]

Q3 2019 Radian Group Inc Earnings Call …read more […]

Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won’t get… …read more […]

(Bloomberg) — Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.The chief executive officer of jewelry maker Pandora A/S is trying to reassure investors that better days are around the corner, after a profit warning on Tuesday sent the company’s shares plunging as much as 13%.“Normally I don’t focus on what happens with the share price, but in this case I think it’s relevant to say why people should consider Pandora as a holding,” CEO Alexander Lacik said in a phone interview.Pandora, which makes mid-priced jewelry, delivered its first net loss since …read more […]

A look at the shareholders of Amazon.com, Inc. (NASDAQ:AMZN) can tell us which group is most powerful. Institutions… …read more […]

Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen’s $4 billion seller Neulasta drug, helping the Swiss drugmaker in its uphill battle to sell copies of rivals’ blockbusters in the world’s top drug market. Novartis’s biosimilar, called Ziextenzo, is aimed at helping cancer patients boost infection-fighting white blood cells during chemotherapy. …read more […]